Mahaffey Kenneth W. and Jardine Meg J. and Bompoint Severine and Cannon Christopher P. and Neal Bruce and Heerspink Hiddo J.L. and Charytan David M. and Edwards Robert and Agarwal Rajiv and Bakris George and Bull Scott and Kollaborációs szervezet: REDENCE Study Investigators and Keltai Katalin and Takács Róbert and et al.:
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial.
CIRCULATION, 140 (9).
pp. 739-750.
ISSN 0009-7322
(2019)
Perkovic Vlado and Jardine Meg J and Neal Bruce and Bompoint Severine and Heerspink Hiddo J L and Charytan David M. and Edwards Robert and Agarwal Rajiv and Bakris George and Bull Scott and Cannon Christopher P. and Capuano George and Kollaborációs szervezet: CREDENCE Trial Investigators and Takács Róbert and et al.:
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
NEW ENGLAND JOURNAL OF MEDICINE, 380 (24).
pp. 2295-2306.
ISSN 0028-4793
(2019)
Jardine Meg J. and Mahaffey Kenneth W. and Neal Bruce and Agarwal Rajiv and Bakris George L. and Brenner Barry M. and Kollaborációs szervezet: CREDENCE study investigators and Csecsei Gyöngyi and Csiky Botond and Danos Péter and Deák László and Dudás Mihály and Keltai Katalin and Takács Róbert and Rosivall László and et al.:
The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics.
AMERICAN JOURNAL OF NEPHROLOGY, 46 (6).
pp. 462-472.
ISSN 0250-8095
(2017)